Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSThe intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease ModelsPersonalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors.Investigation of the bindings of a class of inhibitors with GSK3β kinase using thermodynamic integration MD simulation and kinase assay.Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.
P2860
Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Structural features underlying ...... ions for rational drug design.
@en
Structural features underlying ...... ions for rational drug design.
@nl
type
label
Structural features underlying ...... ions for rational drug design.
@en
Structural features underlying ...... ions for rational drug design.
@nl
prefLabel
Structural features underlying ...... ions for rational drug design.
@en
Structural features underlying ...... ions for rational drug design.
@nl
P2093
P2860
P1476
Structural features underlying ...... ions for rational drug design.
@en
P2093
Rugang Zhong
Yongjun Jiang
P2860
P304
P356
10.1111/J.1747-0285.2010.01069.X
P577
2011-01-19T00:00:00Z